Analysts from RHB Group Research and CGS-CIMB Research have given mixed reactions to UG Healthcare’s announcement on July 12 that it was halting operations of its manufacturing plants in Seremban temporarily due to Malaysia's Enhanced Movement Control Order (EMCO) from July 9 to July 22.
See also: UG Healthcare to see further 2.4% drop in glove production due to EMCO
RHB’s Singapore research team views the development as negative to UG Healthcare’s near-term earnings. The company disclosed that the plant closure will affect its production by 80 million pieces of gloves, or 2.35% of total production.
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
